Cesar A Rodriguez (César A Rodríguez Sánchez, César A Rodríguez)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Ejection Fraction

Metastatic Breast Cancer

Top Venues

Future oncology (London, England)

International journal of clinical pharmacy

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eduardo Terán, Rebeca Lozano, Cesar A Rodriguez, Mar Abad, Luis Figuero, José Antonio Muñoz, Belén Cigarral, Aline Rodrígues, Magdalena Sancho, M Asunción Gómez, Daniel Morchón, Juan Carlos Montero, Jose Maria Sayagues Manzano, M Dolores Ludeña, Emilio Fonseca
PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2- breast cancer. Cancer medicine 13 (17) (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) 20 (13) (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) (2024)
Blanca Herrero López, Ana Cardeña Gutiérrez, Ana Godoy-Ortiz, Ana Gonzaga López, Ana María Grueso López, Ana Nuño Alves, Patricia Ramírez Daffós, Cesar A Rodriguez, Rodriguez-Perez Ar, Víctor Sacristán Santos, Salvador Saura Grau, Sebio-García Raquel, Miguel Ángel Seguí Palmer
Exercise in cancer patients: assistance levels and referral pathways-a position statement from the Spanish Society of Medical Oncology. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) 20 (13) (2024)
Laura Pedraza-Nieto, Mónica Beunza-Sola, Cesar A Rodriguez, Esther Moreno Rodilla, MarÃ A JosÃ Otero
Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds. International journal of clinical pharmacy 43 (4) (2021)
Cesar A Rodriguez, Teresa Martin, Rebeca Lozano, Amalia Gomez, Juan J Cruz
Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer. The breast journal 23 (6) (2017)